4//SEC Filing
BILINSKY IGOR 4
Accession 0001104659-25-118169
CIK 0001425205other
Filed
Dec 2, 7:00 PM ET
Accepted
Dec 3, 5:02 PM ET
Size
15.1 KB
Accession
0001104659-25-118169
Insider Transaction Report
Form 4
BILINSKY IGOR
Chief Operating Officer
Transactions
- Exercise/Conversion
Common Stock
2025-12-01+8,789→ 108,478 total - Tax Payment
Common Stock
2025-12-01$2.23/sh−4,464$9,955→ 104,014 total - Exercise/Conversion
Common Stock
2025-12-02+3,516→ 107,530 total - Tax Payment
Common Stock
2025-12-02$2.14/sh−1,786$3,822→ 105,744 total - Exercise/Conversion
Restricted Stock Units
2025-12-01−8,789→ 43,949 total→ Common stock (8,789 underlying) - Exercise/Conversion
Restricted Stock Units
2025-12-02−3,516→ 3,517 total→ Common stock (3,516 underlying)
Footnotes (7)
- [F1]Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date.
- [F2]Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities.
- [F3]Represents common stock remaining after deducting the common stock withheld for taxes.
- [F4]Each RSU represents a contingent right to receive one share of the Issuer's common stock.
- [F5]The remaining RSUs will vest in equal quarterly installments.
- [F6]Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person.
- [F7]Such aggregate number reflects the remainder of such RSUs granted on March 2, 2023, but does not include any other RSUs held by such Reporting Person.
Documents
Issuer
IOVANCE BIOTHERAPEUTICS, INC.
CIK 0001425205
Entity typeother
Related Parties
1- filerCIK 0001594604
Filing Metadata
- Form type
- 4
- Filed
- Dec 2, 7:00 PM ET
- Accepted
- Dec 3, 5:02 PM ET
- Size
- 15.1 KB